Skip to main content
. 2017 Feb 6;12(2):e0171438. doi: 10.1371/journal.pone.0171438

Table 5. Impact of PCV and Hib vaccination on a birth cohort of 122,747, the number of babies born in Beijing in 2012 [1], assuming %Pneumonia to be 26.9% at age 3.

We used the Lucero value for VEPCV, 27% (15%, 36%) [63] and the Theodoratou value for VEHib, 18% (-2%, 33%) [13]. Potential pneumonia reductions are given for both wholly unvaccinated and vaccinated populations as we have estimated for Beijing.

Vaccine % Vaccinated NT,u Vaccination reduces to %Pneumonia from 26.9% this %.a (95% CI) This many fewer children get pneumonia (95% CI)
PCV 0 122,747 19.6 (22.9, 17.2) 8915 (4953, 11887)
Hib 0 122,747 22.1 (26.9, 21.7) 5943 (0, 10896)
PCV+Hib 0 122,747 14.8 (22.9, 12.1) 14,858 (4953, 22783)
PCVb 1.2 121,274 19.7 (22.9, 17.3) 8808 (4893, 11744)
Hibb 41 72,421 24.9 (26.9, 21.7) 3507 (0, 6429)
PCV+Hib - - 16.9 (22.9, 12.1) 12,315 (4893,18173)

aIv,PCV = Iu (1 − VEPCV). Iv,Hib = Iu (1 − VEHib). Iv,PCV + Hib = (nT,unT,v)/NT.VEPCV: 27% (95%CI: 15%, 36%) [63]. VEHib: 18% (95%CI: -2%, 33%) [13].

b Estimated using data from Shanghai [18], and assuming that Beijing voluntary vaccination rates are approximately the same as those in Shanghai.